|
National Stock Number(NSN): 6505-01-185-5570 (6505011855570, 011855570)
| NIIN: |
01-185-5570 |
Item Name: |
RESERPINE,HYDRALAZINE HYDROCHLORIDE,AND HYDROCHLOROTHIAZIDE TABLETS |
INC: |
27233
|
| FSC: |
6505
|
Assignment Date: |
Jul-31-1984 |
CRIT: |
X |
IIG: |
27233 |
| ISC: |
5 |
Date Standardized: |
Jul-31-1984 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-31-2022 |
PMIC: |
U |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9220 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00083-0071-32 |
04482
|
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
15.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT AND 0.100 MILLIGRAMS RESERPINE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDRALAZINE HYDROCHLORIDE ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
INDIVIDUALLY SEALED |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
100.000 TABLETS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G65V |
|
Apr-01-1991 |
0 |
0 |
|
|
54|65 |
54|65 |
|